NCT05029063 2025-07-09
TRIM-Line
Ottawa Hospital Research Institute
Phase 3 Recruiting
Clinical Trials
13 trialsNCT03506815 2024-07-05
TRIM-Line
Ottawa Hospital Research Institute
Phase 3 Completed
NCT06065592 2023-10-06
CAT_PB
Lebanese University
Phase 1 Unknown
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT01999179 2022-05-18
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Phase NA Completed
NCT04999176 2021-08-10
VALERIA
Science Valley Research Institute
Phase 3 Unknown
NCT02583191 2021-05-03
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
AIO-Studien-gGmbH
Phase 3 Terminated
NCT04256525 2020-06-30
Prophylactic Anticoagulation for Catheter-related Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT04309240 2020-03-16
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
LiuZhou People's Hospital
Phase 3 Unknown
NCT01727427 2019-08-08
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Completed
NCT03282643 2019-04-16
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Capital Medical University
Phase 1/2 Completed
NCT02746185 2018-08-13
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT01708850 2016-09-08
Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
London Health Sciences Centre
Phase 4 Completed